Skip to main content
Medical information Clinical review pending

Genetic Testing

Lrrc6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to identify mutations in the Lrrc6 gene associated with Primary Ciliary Dyskinesia (PCD), a condition affecting cilia movement and respiratory health.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Confirm turnaround time with the laboratory before booking.
Preparation
No special preparation is typically required for a blood draw. However, confirm with the laboratory for any specific instructions.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Lrrc6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Chronic respiratory infections
  • ✓Chronic sinusitis
  • ✓Unexplained infertility
  • ✓Frequent ear infections
  • ✓Family history of Primary Ciliary Dyskinesia (PCD)
  • ✓Symptoms suggestive of ciliary dysfunction
02

In plain language

What this test helps you understand

This test helps confirm or rule out a diagnosis of Primary Ciliary Dyskinesia (PCD) caused by mutations in the Lrrc6 gene. Identifying the specific genetic cause can guide treatment decisions and management strategies for affected individuals.
This test analyzes the Lrrc6 gene to help diagnose Primary Ciliary Dyskinesia (PCD), a genetic disorder affecting the cilia lining the respiratory tract. Cilia are tiny hair-like structures essential for clearing mucus and debris. When they don't function correctly due to PCD, it can lead to chronic respiratory infections, sinusitis, and other health issues. This test uses advanced Next-Generation Sequencing (NGS) technology for a detailed analysis of the Lrrc6 gene. Understanding if PCD is present allows for appropriate management and treatment strategies to be put in place.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for a blood draw. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) is used to analyze the Lrrc6 gene for specific mutations associated with Primary Ciliary Dyskinesia.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the Lrrc6 gene. PCD can be caused by mutations in other genes not covered by this test. A negative result does not completely rule out PCD. Interpretation requires clinical correlation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

PCD is a genetic disorder where the cilia, tiny hair-like structures in the airways, don't work properly. This can lead to chronic respiratory problems.
This test specifically looks for mutations (changes) in the Lrrc6 gene, which is one of the genes linked to PCD.
Individuals with persistent respiratory infections, chronic sinusitis, unexplained infertility, or a family history of PCD may be candidates for this test.
A healthcare provider or genetic counselor will explain the results, including what any identified mutations mean for your health and potential management options.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
A blood sample is typically required for this test. The laboratory can provide details on collection procedures.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp